Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Athira Pharma, Inc. | atha-ex322_575.htm |
| EX-32.1 - EX-32.1 - Athira Pharma, Inc. | atha-ex321_574.htm |
| EX-31.2 - EX-31.2 - Athira Pharma, Inc. | atha-ex312_577.htm |
| EX-31.1 - EX-31.1 - Athira Pharma, Inc. | atha-ex311_576.htm |
| EX-4.3 - EX-4.3 - Athira Pharma, Inc. | atha-ex43_578.htm |
| 10-K - 10-K - Athira Pharma, Inc. | atha-10k_20201231.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-248910) pertaining to the 2020 Equity Incentive Plan, the 2020 Employee Stock Purchase Plan, and the 2014 Equity Incentive Plan, as amended, of Athira Pharma, Inc., of our report dated March 25, 2021, with respect to the consolidated financial statements of Athira Pharma, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Seattle, Washington
March 25, 2021